Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 10/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 10/20 | 0.37 |
| ▸ | FAAH | O00519 | 3/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4079967 | 0.83 | CNR2 (0.51) | FAAHEPHX2CNR2 | |
| SCHEMBL23912878 | 0.80 | SLC6A4 (0.38) | FAAHEPHX2 | |
| SCHEMBL24433911 | 0.79 | FAAH (0.34) | FAAHCNR2 | |
| SCHEMBL24454997 | 0.78 | CNR2 (0.44) | FAAHEPHX2CNR2 | |
| SCHEMBL24433939 | 0.78 | FAAH (0.39) | FAAH | |
| SCHEMBL4087343 | 0.76 | CYP2C19 (0.41) | OPRM1OPRL1FAAHCNR2 | |
| SCHEMBL4079984 | 0.76 | EPHX2 (0.40) | EPHX2CNR2 | |
| SCHEMBL4079982 | 0.76 | EPHX2 (0.40) | EPHX2CNR2 | |
| SCHEMBL4077682 | 0.75 | FAAH (0.42) | FAAHCNR2 | |
| SCHEMBL4075655 | 0.74 | CNR1 (0.51) | OPRM1OPRL1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11141404-B1 | Formulations and methods for treating acute cannabinoid overdose | ANEBULO PHARMACEUTICALS, INC. (US) | 2021-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11141404-B1 | Formulations and methods for treating acute cannabinoid overdose | CNR1, CNR2, FAAH | OPRM1 18/4885OPRL1 12/4885FAAH 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.